MG
NCNA

Michael Gelband’s NuCana NCNA Stock Holding History

Michael Gelband’s Portfolio NCNA Stock Details NCNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6
Closed -$166K – 2238
2020
Q3 		$166K Buy
+6
New +$163K ﹤0.01% 1524

Other funds holding NCNA

SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Michael Gelband's NCNA Position: Q4 2020 in Review

Michael Gelband sold out of NuCana (NCNA) in Q4 2020, closing a stake of 6 shares — an estimated $166K sold.

Michael Gelband first reported a position in NCNA in Q3 2020 and held it in 1 quarter. The position peaked at $166K in Q3 2020. 26 funds tracked by Wall St. Rank hold NCNA as of Q4 2020.

  • Michael Gelband reported no remaining NuCana position as of Q4 2020 after selling out during the quarter.
  • Michael Gelband sold 6 NuCana shares in Q4 2020, an estimated $166K.
  • Michael Gelband first reported a position in NuCana in Q3 2020 and held it in 1 quarter.
  • Michael Gelband's NuCana position peaked at $166K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held NuCana as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.